PURGENESIS TECHNOLOGIES
DEAD

Serial Number

85183296

Owner

PURGENESIS TECHNOLOGIES INC.

Attorney

George A. Pelletier, Jr

Filing Date

Nov 23, 2010

Add to watchlist:

No watchlists yet
View on USPTO

PURGENESIS TECHNOLOGIES Trademark

Serial Number: 85183296

PURGENESIS TECHNOLOGIES is a trademark filed by PURGENESIS TECHNOLOGIES INC. on November 23, 2010. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 4 (Lubricants & Fuels), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

PURGENESIS TECHNOLOGIES INC. (7 trademarks)

360, RUE DES ENTREPRENEURS
MONTMAGNY (QUEBEC) G5V4T1 , CA

Entity Type: 03

Trademark Details

Filing Date

November 23, 2010

Registration Date

Not Registered

Goods & Services

Manufacture of advanced pharmaceutical products to the order and/or specification of others; Manufacture of advanced botanical products to the order and/or specification of others; Manufacture of advanced biosensors to the order and specification of others; Manufacture of advanced biofuels to the order and specification of others; Manufacture of advanced cosmeceutical products to the order and specification of others; Manufacture of advanced hair care, cosmetic, tooth and mouth care and body care products to the order and specification of others; Manufacture of advanced medical devices to the order and specification of others

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the treatment and of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of a symptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic orthrombolytic agents for the treatment of arterial, pulmonary and heart disease and afflictions and to restore arterial and vascular patency in order to prevent loss of tissue, limb and organ function; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, auto immune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; and nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals that control the solubility, compressibility and/or flow ability of drugs; oral extended release pharmaceuticals for the treatment of angina and hypertension; rapidly dissolving matrix pharmaceutical preparations to which may be added medicinal active ingredients for the treatment of dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal related diseases and disorders for humans and for veterinary use; Botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; botanical naturopathic pharmaceutical preparations and substances for the cessation of smoking; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; botanical based anti-depressants; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of a symptomatic left ventricular dysfunction; botanical naturopathic pharmaceutical preparations and substances, namely, fibrinolytic orthrombolytic agents for the treatment of arterial, pulmonary and heart disease and afflictions and to restore arterial and vascular patency in order to prevent loss of tissue, limb and organ function; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, auto immune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation namely, pain relief medication and anti inflammatories; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; botanical naturopathic pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; botanical naturopathic pharmaceutical preparations and substances, namely, botanical skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; botanical naturopathic pharmaceutical preparations and substances for use in oncology; botanical naturopathic pharmaceutical preparations and substances for use in ophthalmology; and botanical based nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; botanical naturopathic pharmaceutical preparation and substance delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals that control the solubility, compressibility and/or flow ability of botanical preparations and substances; oral extended release botanical naturopathic pharmaceutical preparations and substances for the treatment of angina and hypertension; rapidly dissolving matrix botanical and naturopathic pharmaceutical preparations to which may be added botanical active ingredients for the treatment of dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal related diseases and disorders for humans and for veterinary use; Rinse, namely, dandruff shampoo for controlling, preventing and treating dandruff; Cosmeceutical products, namely, general and advanced medicated hair care preparations; bone implants comprising live tissue, cosmetic surgery implants comprising live tissue

Paper towels, facial tissues

Biofuels, namely, gaseous, solid and liquid fuel derived from plant and other biomass material

Cosmetic products, namely, nail polish, nail varnish, nail polish remover, nail conditioner, emery paper; pumice stone for personal use; cosmetic dyes, namely, hair dyes; anti-aging creams and serums, suntan lotion, suntan oil, sun tan lotion, sun screen, sun block, after sun lotion, self-tanning and reconstructive preparations in the nature of colorants for the face, namely, skin tanning lotion and cream, skin tanning spray; depilatories; lipstick, lip gloss, lip balm, lip sun screen, eyeliner, mascara, eye shadow, eye brow pencil, face powder, foundation liquid and cream, liquid make up, powder make up, liquid blush, powder blush, make-up removing preparations; make up compacts containing makeup and puff, blusher compacts containing blush and brush, lip stick and lip gloss compacts containing lipstick and lip gloss with applicator; cotton swabs for cosmetic purposes; cotton balls for cosmetic purposes; Tooth and mouth care products, namely, tooth gel, tooth paste, tooth polish, tooth powder, tooth whitener and bleach; and mouthwash; Body care products, namely, essential oil, massage oil, cleansing lotion and cleansing oil, astringents for cosmetic purposes, night cream, anti wrinkle cream and lotion, barrier cream, namely, body cream and mud, mask preparation for treating the skin, bath salts, bubble bath, bath foam, bath oil, bath and shower gel, liquid and bar soap for personal use, body scrub and exfoliant, shaving soap, antiperspirant, talcum powder, body powder, perfume, eau de cologne, deodorant for personal use, perfuming sachets

Retail and wholesale store services featuring advanced pharmaceutical products; Retail and wholesale store and consulting services featuring advanced botanical products; retail and wholesale store services featuring advanced biosensors; Retail and wholesale store services featuring advanced biofuels; Retail and wholesale store services featuring advanced cosmeceutical products; Retail and wholesale store services featuring advanced hair care, cosmetic, tooth and mouth care and body care products; and Retail and wholesale store services featuring advanced medical devices

Extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary medicinal products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary medicinal products for the treatment of infertility, diabetes, and/or insulin imbalances; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary botanical products for the treatment of circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents, namely, chemical additives and botanical extracts, namely, extracts coming from green plants, red plants, seaweed, micro and macro algae, brown algae and bacteria for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances

Licensing of pharmaceutical compounds; licensing of botanical products; licensing of biosensors; licensing of biofuels; licensing of cosmeceutical products; licensing of hair care, cosmetic, tooth and mouth care and body care products; licensing of medical devices

Biosensors for the identification and determination of concentration of substances and other parameters of biological interest, namely, biosensors for detecting diseases, biologic indicators and biologic anomalies; Medical devices, namely, medical instruments for use in performing biopsies, diagnosing and treating cardiovascular, dermatological, cardiopulmonary, respiratory, neurological, gastrointestinal diseases and trauma, fractures, and conducting surgery for human and veterinary use; implantable and extra-corporeal medical devices for human and veterinary non-invasive or surgical repair, fixation, support, immobilization or stabilization of trauma, fractures, disease, disorders, conditions and ailments, namely, screws, plates, cerclage wiring, sutures, pacemakers, internal and external drug delivery systems, bone implants composed of artificial materials, stents, cosmetic surgery implants composed of artificial materials, artificial limbs, lenses for surgical implantation and hearing aids; Bone prostheses for human and veterinary use; Tooth and mouth care products, namely, gum stimulators, tongue scrapers, and palette and soft tissue cleaners in the nature of sprayers for cleaning gums and teeth used in dentists' offices during dental procedures

Research and development in the field of pharmaceuticals; development of pharmaceutical preparations; clinical evaluation and testing of pharmaceutical compounds; research and development in the field of botanical naturopathic and pharmaceutical products; development of botanical naturopathic and pharmaceutical preparations; clinical evaluation and testing of botanical naturopathic and pharmaceutical products; scientific research and development in the field of biosensors; product development in the field of biosensors; Testing of new products for others in the field of biosensors; scientific research and development in the field of biofuels; Product development in the field of biofuels; testing of new products for others in the field of biofuels; scientific research and development in the field of cosmeceutical products; product development in the field of cosmeceutical products; testing of new products for others in the field of cosmeceutical products; scientific research and development in the field of hair care, cosmetic, tooth and mouth care and body care products; product development in the field of hair care, cosmetic, tooth and mouth care and body care products; testing of new products for others in the field of hair care, cosmetic, tooth and mouth care and body care products; scientific research and development in the field of medical devices; product development in the field of medical devices; testing of new products for others in the field of medical devices

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 9, 2016 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 9, 2016 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 14, 2015 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 14, 2015 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 14, 2015 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 8, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 8, 2015 GNSL
SUSPENSION LETTER WRITTEN
Jan 8, 2015 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2014 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 3, 2014 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 2, 2014 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 2, 2014 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 2, 2014 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 2, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 2, 2014 GNSL
SUSPENSION LETTER WRITTEN
Jan 2, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2013 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 19, 2013 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 26, 2013 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 26, 2013 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 26, 2013 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 20, 2013 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 14, 2012 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 14, 2012 GNSL
SUSPENSION LETTER WRITTEN
Nov 14, 2012 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2012 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 12, 2012 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 10, 2012 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 10, 2012 GNSI
SUSPENSION INQUIRY WRITTEN
May 10, 2012 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 3, 2012 RCCK
ASSIGNED TO LIE
Apr 3, 2012 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 29, 2011 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 29, 2011 GNSL
SUSPENSION LETTER WRITTEN
Sep 29, 2011 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2011 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2011 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2011 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2011 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Nov 30, 2010 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2010 NWOS
NEW APPLICATION ENTERED
Nov 26, 2010 NWAP